TD Asset Management’s CRH Medical Corporation CRHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-63,689
Closed -$84K 1447
2020
Q1
$84K Buy
63,689
+1,160
+2% +$3.79K ﹤0.01% 1348
2019
Q4
$217K Sell
62,529
-544
-0.9% -$1.72K ﹤0.01% 1360
2019
Q3
$194K Sell
63,073
-13,705
-18% -$40.7K ﹤0.01% 1307
2019
Q2
$231K Sell
76,778
-20,815
-21% -$59.5K ﹤0.01% 1286
2019
Q1
$258K Sell
97,593
-6,012
-6% -$18.6K ﹤0.01% 1277
2018
Q4
$317K Sell
103,605
-4,233
-4% -$13.9K ﹤0.01% 1297
2018
Q3
$429K Sell
107,838
-1,918
-2% -$7.07K ﹤0.01% 1324
2018
Q2
$343K Buy
109,756
+3,333
+3% +$10.6K ﹤0.01% 1339
2018
Q1
$269K Buy
106,423
+5,677
+6% +$15.9K ﹤0.01% 1289
2017
Q4
$266K Sell
100,746
-10,308
-9% -$23K ﹤0.01% 1271
2017
Q3
$289K Buy
111,054
+43,851
+65% +$135K ﹤0.01% 1241
2017
Q2
$382K Buy
67,203
+24,596
+58% +$160K ﹤0.01% 1225
2017
Q1
$347K Buy
42,607
+3,124
+8% +$21.6K ﹤0.01% 1298
2016
Q4
$211K Buy
39,483
+15,683
+66% +$79.5K ﹤0.01% 1335
2016
Q3
$92K Buy
+23,800
New +$91K ﹤0.01% 1387
2016
Q2
Sell
-21,552
Closed -$71K 1392
2016
Q1
$71K Buy
21,552
+10,371
+93% +$29.7K ﹤0.01% 1346
2015
Q4
$33K Buy
+11,181
New +$31K ﹤0.01% 1354

Other funds holding CRHM

TD Asset Management's CRHM Position: Q2 2020 in Review

TD Asset Management sold out of CRH Medical Corporation (CRHM) in Q2 2020, closing a stake of 63,689 shares — an estimated $84K sold.

TD Asset Management first reported a position in CRHM in Q4 2015 and held it in 17 quarters. The position peaked at $429K in Q3 2018. 44 funds tracked by Wall St. Rank hold CRHM as of Q2 2020.

  • TD Asset Management reported no remaining CRH Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • TD Asset Management sold 63,689 CRH Medical Corporation shares in Q2 2020, an estimated $84K.
  • TD Asset Management first reported a position in CRH Medical Corporation in Q4 2015 and held it in 17 quarters.
  • TD Asset Management's CRH Medical Corporation position peaked at $429K in Q3 2018.
  • 44 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2020.

Based on TD Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.